Maslennikov Roman, Pavlov Chavdar, Ivashkin Vladimir
Department of Gastroenterology and Hepatology, Sechenov University, Moscow, Russia.
Turk J Gastroenterol. 2019 Nov;30(11):964-975. doi: 10.5152/tjg.2019.18551.
BACKGROUND/AIMS: Small intestinal bacterial overgrowth (SIBO) and hemodynamic changes are common in cirrhosis. We wanted to examine our hypothesis whether SIBO leads to hemodynamic changes in cirrhosis.
A total of 50 patients with cirrhosis and 15 healthy controls were enrolled in a pilot prospective study. All participants underwent the lactulose hydrogen breath test for SIBO and echocardiography with a simultaneous assessment of blood pressure and heart rate. Cardiac output and systemic vascular resistance were calculated.
Study participants with SIBO had a lower systolic blood pressure and systemic vascular resistance compared to those without SIBO and to healthy controls (110.2±12.3 mmHg vs. 126.2±21.0 mmHg and 121.2±9.8 mmHg; p=0.005 and p=0.011, respectively; 1312±352 dyn•s•cm-5 vs. 1704±424 dyn•s•cm-5 and 1648±272 dyn•s•cm-5; p=0.001 and p=0.006, respectively), but a higher cardiac output (5.38±1.41 l/min vs. 4.52±1.03 l/min and 4.40±0.68 l/min; p=0.034 and p=0.041, respectively) and C-reactive protein (10.5[1.2-16.5] mg/l vs. 2.8[0.6-9.1] mg/l; p=0.028; no comparison with healthy controls). There were no significant differences between patients without SIBO and healthy controls with regard to systolic blood pressure (p=0.554), systemic vascular resistance (p=0.874), and cardiac output (p=0.795). SIBO was associated with vasodilation and hyperdynamic circulation in decompensated cirrhosis (p=0.002; p=0.012), but not in compensated cirrhosis (p=1.000; p=0.474).
SIBO is associated with hyperdynamic circulation and other hemodynamic changes in cirrhosis and may be a principal factor causing these through systemic inflammation.
背景/目的:小肠细菌过度生长(SIBO)和血流动力学改变在肝硬化患者中很常见。我们想要验证我们的假设,即SIBO是否会导致肝硬化患者的血流动力学改变。
一项前瞻性试点研究纳入了50例肝硬化患者和15例健康对照者。所有参与者均接受了用于检测SIBO的乳果糖氢呼气试验以及超声心动图检查,并同时评估血压和心率。计算心输出量和全身血管阻力。
与无SIBO的患者及健康对照者相比,患有SIBO的研究参与者收缩压和全身血管阻力更低(分别为110.2±12.3 mmHg vs. 126.2±21.0 mmHg和121.2±9.8 mmHg;p = 0.005和p = 0.011;1312±352 dyn•s•cm-5 vs. 1704±424 dyn•s•cm-5和1648±272 dyn•s•cm-5;p = 0.001和p = 0.006),但心输出量更高(分别为5.38±1.41 l/min vs. 4.52±1.03 l/min和4.40±0.68 l/min;p = 0.034和p = 0.041),C反应蛋白水平也更高(10.5[1.2 - 16.5] mg/l vs. 2.8[0.6 - 9.1] mg/l;p = 0.028;未与健康对照者比较)。在收缩压(p = 0.554)、全身血管阻力(p = 0.874)和心输出量(p = 0.795)方面,无SIBO的患者与健康对照者之间无显著差异。SIBO与失代偿期肝硬化的血管舒张和高动力循环相关(p = 0.002;p = 0.012),但与代偿期肝硬化无关(p = 1.000;p = 0.474)。
SIBO与肝硬化患者的高动力循环及其他血流动力学改变相关,可能是通过全身炎症导致这些改变的主要因素。